Cargando…

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability

BACKGROUND: The objectives and goals of the Southern Swedish Malignant Melanoma (SSMM) are to develop, build and utilize cutting edge biobanks and OMICS platforms to better understand disease pathology and drug mechanisms. The SSMM research team is a truly cross-functional group with members from on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Welinder, Charlotte, Jönsson, Göran, Ingvar, Christian, Lundgren, Lotta, Olsson, Håkan, Breslin, Thomas, Végvári, Ákos, Laurell, Thomas, Rezeli, Melinda, Jansson, Bo, Baldetorp, Bo, Marko-Varga, György
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599425/ https://www.ncbi.nlm.nih.gov/pubmed/23445834 http://dx.doi.org/10.1186/2001-1326-2-7

Ejemplares similares

Analysis of Alpha-Synuclein in Malignant Melanoma – Development of a SRM Quantification Assay
por: Welinder, Charlotte, et al.
Publicado: (2014)

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues
por: Welinder, Charlotte, et al.
Publicado: (2015)

Correlation of histopathologic characteristics to protein expression and function in malignant melanoma
por: Welinder, Charlotte, et al.
Publicado: (2017)

Moving towards high density clinical signature studies with a human proteome catalogue developing multiplexing mass spectrometry assay panels
por: Rezeli, Melinda, et al.
Publicado: (2011)

Biobank resources for future patient care: developments, principles and concepts
por: Végvári, Ákos, et al.
Publicado: (2011)

Standardization developments for large scale biobanks in smoking related diseases - a model system for blood sample processing and storage
por: Malm, Johan, et al.
Publicado: (2013)

Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Endogenous expression mapping of malignant melanoma by mass spectrometry imaging
por: Sugihara, Yutaka, et al.
Publicado: (2018)

Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine
por: Marko-Varga, György, et al.
Publicado: (2012)

Primary Breast Cancer Tumours Contain High Amounts of IgA1 Immunoglobulin: An Immunohistochemical Analysis of a Possible Carrier of the Tumour-Associated Tn Antigen
por: Welinder, Charlotte, et al.
Publicado: (2013)

Proteomic profiling of extracellular vesicles reveals additional diagnostic biomarkers for myocardial infarction compared to plasma alone
por: Gidlöf, Olof, et al.
Publicado: (2019)

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes
por: Betancourt, Lazaro Hiram, et al.
Publicado: (2019)

Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
por: Kim, Yonghyo, et al.
Publicado: (2020)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
por: Sanchez, Aniel, et al.
Publicado: (2019)

Clinical protein science in translational medicine targeting malignant melanoma
por: Gil, Jeovanis, et al.
Publicado: (2019)

Semi-automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies
por: Malm, Johan, et al.
Publicado: (2015)

Localization of tamoxifen in human breast cancer tumors by MALDI mass spectrometry imaging
por: Végvári, Ákos, et al.
Publicado: (2016)

Clinical initiatives linking Japanese and Swedish healthcare resources on cancer studies utilizing Biobank Repositories
por: Nishimura, Toshihide, et al.
Publicado: (2014)

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.
por: Welinder, Charlotte, et al.
Publicado: (2016)

Systematic Identification of Single Amino Acid Variants in Glioma Stem-Cell-Derived Chromosome 19 Proteins
por: Lichti, Cheryl F., et al.
Publicado: (2014)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

Limited Tumor Tissue Drug Penetration Contributes to Primary Resistance against Angiogenesis Inhibitors
por: Torok, Szilvia, et al.
Publicado: (2017)

Deep Proteomic Analysis on Biobanked Paraffine-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out
por: Szadai, Leticia, et al.
Publicado: (2021)

Clusterwise Peak Detection and Filtering Based on Spatial Distribution To Efficiently Mine Mass Spectrometry Imaging Data
por: Eriksson, Jonatan O., et al.
Publicado: (2019)

BioBanking - The Holy Grail of novel drug and diagnostic developments?
por: Marko-Varga, György
Publicado: (2011)

Visualisation of H(2)O(2) penetration through skin indicates importance to develop pathway-specific epidermal sensing
por: Jankovskaja, Skaidre, et al.
Publicado: (2020)

Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways
por: Johansson, Madeleine, et al.
Publicado: (2022)

Non-invasive skin sampling of tryptophan/kynurenine ratio in vitro towards a skin cancer biomarker
por: Jankovskaja, Skaidre, et al.
Publicado: (2021)

BioBanking as the central tool for translational medicine CTM issue 2013
por: Marko-Varga, György
Publicado: (2013)

Correction: Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue
por: Murillo, Jimmy Rodriguez, et al.
Publicado: (2018)

Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue
por: Murillo, Jimmy Rodriguez, et al.
Publicado: (2018)

MSIWarp: A General Approach to Mass Alignment in Mass Spectrometry Imaging
por: Eriksson, Jonatan O., et al.
Publicado: (2020)

Identification and Validation of VEGFR2 Kinase as a Target of Voacangine by a Systematic Combination of DARTS and MSI
por: Kim, Yonghyo, et al.
Publicado: (2020)

Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer
por: Staaf, Johan, et al.
Publicado: (2011)

Perceived changes in capability during the COVID-19 pandemic: A Swedish cross-sectional study from June 2020
por: Meili, Kaspar Walter, et al.
Publicado: (2021)

The Swedish Spine Register: development, design and utility
por: Strömqvist, Björn, et al.
Publicado: (2009)

Challenging the heterogeneity of disease presentation in malignant melanoma—impact on patient treatment
por: Marcell Szasz, A., et al.
Publicado: (2018)

2DDB – a bioinformatics solution for analysis of quantitative proteomics data
por: Malmström, Lars, et al.
Publicado: (2006)

Swespine: the Swedish spine register: The 2012 report
por: Strömqvist, Björn, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_bpksfhvm54l6lmn8c4199m502m